Change at the top for Biogen after Alzheimer's drug flops
Biogen is looking for a new CEO less than a year after its launch of its Alzheimer's drug Aduhelm largely fizzled. The company said Tuesday that current CEO Michel Vounatsos will c…
Biogen is looking for a new CEO less than a year after its launch of its Alzheimer's drug Aduhelm largely fizzled. The company said Tuesday that current CEO Michel Vounatsos will c…